Retatrutide: A Triple-Hormone-Receptor Agonist in Early Trials | RemedyX Labs Research Library

A research summary of Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial, examining retatrutide: a triple-hormone-receptor agonist in early trials. Cited source and RUO context from RemedyX Labs.